These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 11452678

  • 21. [Clarithromycin versus amoxicillin-clavulanic acid in the treatment of acute maxillary sinusitis in adults].
    Géhanno P, Barry B, Chauvin JP, Hazebroucq J.
    Pathol Biol (Paris); 1996 Apr; 44(4):293-7. PubMed ID: 8763594
    [Abstract] [Full Text] [Related]

  • 22. Once daily clarithromycin extended-release vs twice-daily amoxicillin/clavulanate in patients with acute bacterial sinusitis: a randomized, investigator-blinded study.
    Riffer E, Spiller J, Palmer R, Shortridge V, Busman TA, Valdes J.
    Curr Med Res Opin; 2005 Jan; 21(1):61-70. PubMed ID: 15881476
    [Abstract] [Full Text] [Related]

  • 23. Moxifloxacin monotherapy compared to amoxicillin-clavulanate plus roxithromycin for nonsevere community-acquired pneumonia in adults with risk factors.
    Portier H, Brambilla C, Garre M, Paganin F, Poubeau P, Zuck P.
    Eur J Clin Microbiol Infect Dis; 2005 Jun; 24(6):367-76. PubMed ID: 15944847
    [Abstract] [Full Text] [Related]

  • 24. A randomized comparative study of levofloxacin versus amoxicillin/clavulanate for treatment of infants and young children with recurrent or persistent acute otitis media.
    Noel GJ, Blumer JL, Pichichero ME, Hedrick JA, Schwartz RH, Balis DA, Melkote R, Bagchi P, Arguedas A.
    Pediatr Infect Dis J; 2008 Jun; 27(6):483-9. PubMed ID: 18449063
    [Abstract] [Full Text] [Related]

  • 25. Oral garenoxacin in the treatment of acute bacterial maxillary sinusitis: a Phase II, multicenter, noncomparative, open-label study in adult patients undergoing sinus aspiration.
    Lopez Sisniega J, Profant M, Kostrica R, Waskin H.
    Clin Ther; 2007 Aug; 29(8):1632-44. PubMed ID: 17919545
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Efficacy of twice-daily amoxycillin/clavulanate in lower respiratory tract infections.
    Balgos AA, Rodriguez-Gomez G, Nasnas R, Mahasur AA, Margono BP, Tinoco-Favila JC, Sansores-Martinez RH, Hassan M, Beppo O, Wongsa A, Cukier A, Vargas F.
    Int J Clin Pract; 1999 Aug; 53(5):325-30. PubMed ID: 10695094
    [Abstract] [Full Text] [Related]

  • 28. Comparison of moxifloxacin and cefuroxime axetil in the treatment of acute maxillary sinusitis. Sinusitis Infection Study Group.
    Burke T, Villanueva C, Mariano H, Huck W, Orchard D, Haverstock D, Heyd A, Church D.
    Clin Ther; 1999 Oct; 21(10):1664-77. PubMed ID: 10566563
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Double-blind, randomized study of the efficacy and safety of oral pharmacokinetically enhanced amoxicillin-clavulanate (2,000/125 milligrams) versus those of amoxicillin-clavulanate (875/125 milligrams), both given twice daily for 7 days, in treatment of bacterial community-acquired pneumonia in adults.
    File TM, Lode H, Kurz H, Kozak R, Xie H, Berkowitz E, 600 Study Group.
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3323-31. PubMed ID: 15328092
    [Abstract] [Full Text] [Related]

  • 33. Clinical efficacy of moxifloxacin in the treatment of bacterial keratitis: a randomized clinical trial.
    Constantinou M, Daniell M, Snibson GR, Vu HT, Taylor HR.
    Ophthalmology; 2007 Sep; 114(9):1622-9. PubMed ID: 17822972
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. A randomized trial of the efficacy and safety of sequential intravenous/oral moxifloxacin monotherapy versus intravenous piperacillin/tazobactam followed by oral amoxicillin/clavulanate for complicated skin and skin structure infections.
    Gyssens IC, Dryden M, Kujath P, Nathwani D, Schaper N, Hampel B, Reimnitz P, Alder J, Arvis P.
    J Antimicrob Chemother; 2011 Nov; 66(11):2632-42. PubMed ID: 21896561
    [Abstract] [Full Text] [Related]

  • 36. Comparative efficacy and safety of oral fleroxacin and amoxicillin/clavulanate potassium in skin and soft tissue infections.
    Tassler H.
    Am J Med; 1993 Mar 22; 94(3A):159S-165S. PubMed ID: 8452174
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Oral antibiotics for fever in low-risk neutropenic patients with cancer: a double-blind, randomized, multicenter trial comparing single daily moxifloxacin with twice daily ciprofloxacin plus amoxicillin/clavulanic acid combination therapy--EORTC infectious diseases group trial XV.
    Kern WV, Marchetti O, Drgona L, Akan H, Aoun M, Akova M, de Bock R, Paesmans M, Viscoli C, Calandra T.
    J Clin Oncol; 2013 Mar 20; 31(9):1149-56. PubMed ID: 23358983
    [Abstract] [Full Text] [Related]

  • 39. Moxifloxacin monotherapy is effective in hospitalized patients with community-acquired pneumonia: the MOTIV study--a randomized clinical trial.
    Torres A, Garau J, Arvis P, Carlet J, Choudhri S, Kureishi A, Le Berre MA, Lode H, Winter J, Read RC, MOTIV (MOxifloxacin Treatment IV) Study Group.
    Clin Infect Dis; 2008 May 15; 46(10):1499-509. PubMed ID: 18419482
    [Abstract] [Full Text] [Related]

  • 40. The efficacy of moxifloxacin in acute exacerbations of chronic bronchitis: a Spanish physician and patient experience.
    Miravitlles M, Ros F, Cobos A, Kubin R, Tillotson G.
    Int J Clin Pract; 2001 Sep 15; 55(7):437-41. PubMed ID: 11594251
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.